Professor Waseem Qasim (UCL Great Ormond Street Institute of Child Health) led a team that treated two young leukaemia patients with an experimental therapy using genetically engineered immune cells from a donor. More than a year later, both girls have no sign of the leukaemia returning. Dr Simon Waddington (UCL Maternal & Fetal Medicine) comments.
Read: The Independent,
More: New Scientist,
Reuters,
The Times,
Mirror
Close
